114 related articles for article (PubMed ID: 17329966)
1. Notches, NFkappaBs and the making of T cell leukemia.
Aifantis I; Vilimas T; Buonamici S
Cell Cycle; 2007 Feb; 6(4):403-6. PubMed ID: 17329966
[TBL] [Abstract][Full Text] [Related]
2. Targeting the NF-kappaB signaling pathway in Notch1-induced T-cell leukemia.
Vilimas T; Mascarenhas J; Palomero T; Mandal M; Buonamici S; Meng F; Thompson B; Spaulding C; Macaroun S; Alegre ML; Kee BL; Ferrando A; Miele L; Aifantis I
Nat Med; 2007 Jan; 13(1):70-7. PubMed ID: 17173050
[TBL] [Abstract][Full Text] [Related]
3. NOTCH1-induced T-cell leukemia in transgenic zebrafish.
Chen J; Jette C; Kanki JP; Aster JC; Look AT; Griffin JD
Leukemia; 2007 Mar; 21(3):462-71. PubMed ID: 17252014
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic NOTCH1 control of MYC and PI3K: challenges and opportunities for anti-NOTCH1 therapy in T-cell acute lymphoblastic leukemias and lymphomas.
Palomero T; Ferrando A
Clin Cancer Res; 2008 Sep; 14(17):5314-7. PubMed ID: 18765521
[TBL] [Abstract][Full Text] [Related]
5. T cell acute lymphoblastic leukemia/lymphoma: a human cancer commonly associated with aberrant NOTCH1 signaling.
Pear WS; Aster JC
Curr Opin Hematol; 2004 Nov; 11(6):426-33. PubMed ID: 15548998
[TBL] [Abstract][Full Text] [Related]
6. Deregulated NOTCH signaling in acute T-cell lymphoblastic leukemia/lymphoma: new insights, questions, and opportunities.
Aster JC
Int J Hematol; 2005 Nov; 82(4):295-301. PubMed ID: 16298817
[TBL] [Abstract][Full Text] [Related]
7. Activity of the selective IκB kinase inhibitor BMS-345541 against T-cell acute lymphoblastic leukemia: involvement of FOXO3a.
Buontempo F; Chiarini F; Bressanin D; Tabellini G; Melchionda F; Pession A; Fini M; Neri LM; McCubrey JA; Martelli AM
Cell Cycle; 2012 Jul; 11(13):2467-75. PubMed ID: 22713244
[TBL] [Abstract][Full Text] [Related]
8. Leukemia-associated mutations within the NOTCH1 heterodimerization domain fall into at least two distinct mechanistic classes.
Malecki MJ; Sanchez-Irizarry C; Mitchell JL; Histen G; Xu ML; Aster JC; Blacklow SC
Mol Cell Biol; 2006 Jun; 26(12):4642-51. PubMed ID: 16738328
[TBL] [Abstract][Full Text] [Related]
9. The tumor suppressor gene hCDC4 is frequently mutated in human T-cell acute lymphoblastic leukemia with functional consequences for Notch signaling.
Malyukova A; Dohda T; von der Lehr N; Akhoondi S; Corcoran M; Heyman M; Spruck C; Grandér D; Lendahl U; Sangfelt O
Cancer Res; 2007 Jun; 67(12):5611-6. PubMed ID: 17575125
[TBL] [Abstract][Full Text] [Related]
10. Critical roles of NOTCH1 in acute T-cell lymphoblastic leukemia.
Liu H; Chiang MY; Pear WS
Int J Hematol; 2011 Aug; 94(2):118-125. PubMed ID: 21814881
[TBL] [Abstract][Full Text] [Related]
11. NOTCH1 mutations in T-cell acute lymphoblastic leukemia: prognostic significance and implication in multifactorial leukemogenesis.
Zhu YM; Zhao WL; Fu JF; Shi JY; Pan Q; Hu J; Gao XD; Chen B; Li JM; Xiong SM; Gu LJ; Tang JY; Liang H; Jiang H; Xue YQ; Shen ZX; Chen Z; Chen SJ
Clin Cancer Res; 2006 May; 12(10):3043-9. PubMed ID: 16707600
[TBL] [Abstract][Full Text] [Related]
12. CUTLL1, a novel human T-cell lymphoma cell line with t(7;9) rearrangement, aberrant NOTCH1 activation and high sensitivity to gamma-secretase inhibitors.
Palomero T; Barnes KC; Real PJ; Glade Bender JL; Sulis ML; Murty VV; Colovai AI; Balbin M; Ferrando AA
Leukemia; 2006 Jul; 20(7):1279-87. PubMed ID: 16688224
[TBL] [Abstract][Full Text] [Related]
13. Constitutive activation of NF-κB signaling by NOTCH1 mutations in chronic lymphocytic leukemia.
Xu ZS; Zhang JS; Zhang JY; Wu SQ; Xiong DL; Chen HJ; Chen ZZ; Zhan R
Oncol Rep; 2015 Apr; 33(4):1609-14. PubMed ID: 25633905
[TBL] [Abstract][Full Text] [Related]
14. The Notch1/c-Myc pathway in T cell leukemia.
Sharma VM; Draheim KM; Kelliher MA
Cell Cycle; 2007 Apr; 6(8):927-30. PubMed ID: 17404512
[TBL] [Abstract][Full Text] [Related]
15. Recent advances on NOTCH signaling in T-ALL.
Tzoneva G; Ferrando AA
Curr Top Microbiol Immunol; 2012; 360():163-82. PubMed ID: 22673746
[TBL] [Abstract][Full Text] [Related]
16. Molecular pathogenesis of T-cell leukaemia and lymphoma.
Aifantis I; Raetz E; Buonamici S
Nat Rev Immunol; 2008 May; 8(5):380-90. PubMed ID: 18421304
[TBL] [Abstract][Full Text] [Related]
17. Detection of NOTCH1 mutations in adult T-cell leukemia/lymphoma and peripheral T-cell lymphoma.
Shimizu D; Taki T; Utsunomiya A; Nakagawa H; Nomura K; Matsumoto Y; Nishida K; Horiike S; Taniwaki M
Int J Hematol; 2007 Apr; 85(3):212-8. PubMed ID: 17483057
[TBL] [Abstract][Full Text] [Related]
18. The NOTCH1/CD44 axis drives pathogenesis in a T cell acute lymphoblastic leukemia model.
García-Peydró M; Fuentes P; Mosquera M; García-León MJ; Alcain J; Rodríguez A; García de Miguel P; Menéndez P; Weijer K; Spits H; Scadden DT; Cuesta-Mateos C; Muñoz-Calleja C; Sánchez-Madrid F; Toribio ML
J Clin Invest; 2018 Jul; 128(7):2802-2818. PubMed ID: 29781813
[TBL] [Abstract][Full Text] [Related]
19. Apoptotic role of IKK in T-ALL therapeutic response.
Riz I; Zweier-Renn LA; Toma I; Hawley TS; Hawley RG
Mol Cancer Res; 2011 Aug; 9(8):979-84. PubMed ID: 21730014
[TBL] [Abstract][Full Text] [Related]
20. c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma.
Weng AP; Millholland JM; Yashiro-Ohtani Y; Arcangeli ML; Lau A; Wai C; Del Bianco C; Rodriguez CG; Sai H; Tobias J; Li Y; Wolfe MS; Shachaf C; Felsher D; Blacklow SC; Pear WS; Aster JC
Genes Dev; 2006 Aug; 20(15):2096-109. PubMed ID: 16847353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
